Replimune Group, Inc. Profile Avatar - Palmy Investing

Replimune Group, Inc.

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against canc…

Biotechnology
US, Woburn [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of REPL's Analysis
CIK: 1737953 CUSIP: 76029N106 ISIN: US76029N1063 LEI: - UEI: -
Secondary Listings
REPL has no secondary listings inside our databases.